Picture of Standard BioTools logo

LAB — Standard BioTools News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Brief: Standard BioTools Reports Prelim Q4 and Full Year 2023 Revenue

Jan 8 (Reuters) - Standard BioTools Inc  LAB.O :
    * STANDARD BIOTOOLS ANNOUNCES PRELIMINARY FOURTH QUARTER AND
FULL
YEAR 2023 REVENUE
    * STANDARD BIOTOOLS INC: EXPECTS Q4 2023 REVENUE OF
APPROXIMATELY
$28 MILLION
    * STANDARD BIOTOOLS INC: SOMALOGIC EXPECTS Q4 2023 REVENUE
OF
APPROXIMATELY $23 MILLION
    * STANDARD BIOTOOLS INC: EXPECTS CASH, CASH EQUIVALENTS AND
SHORT-TERM INVESTMENTS OF COMBINED COMPANY TO BE OVER $550
MILLION AS OF DEC 31, 2023

Source text for Eikon:  ID:nGNX1Sjsd4 
Further company coverage:  LAB.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Standard BioTools

See all news